weight loss pen tirzepatide Wins FDA Approval for Zepbound® - Easy to use

This blog explores the science behind GLP-1 plateaus , why they occur, and what providers can do to prevent, reverse, or bypass them through smart cycling strategies, metabolic support, and adjunctive protocols like SLM+

This dual GIP/GLP-1 receptor agonist (Mounjaro, Zepbound) is not contraindicated in patients who have undergone cholecystectomy, as it does not depend on biliary function for its therapeutic action

Chronic enteropathy distal ileal malabsorption (often alongside tylosin or metronidazole)

The Precision Peptide Genetic Test analyzes 49 peptide pathways and 150+ genetic insights related to GLP-1 response, hunger signaling, and metabolic functionnot reproductive hormone sensitivity

Role of C-reactive protein at sites of inflammation and infection

Cholesterol-dependent transcriptome remodeling reveals new insight into the contribution of cholesterol to Mycobacterium tuberculosis pathogenesis